Medications for Muscle Invasive Bladder Cancer
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Muscle Invasive Bladder Cancer.
Found 1 Approved Drug for Muscle Invasive Bladder Cancer
Padcev Ejfv
Generic Name
Enfortumab Vedotin
Padcev Ejfv
Generic Name
Enfortumab Vedotin
Form: Injection
Method of administration: Intravenous
FDA approval date: December 18, 2019
PADCEV ® is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (mUC) who: have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or, are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy. PADCEV is a Nectin-4-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who:, have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or, are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances